SCHEMBL9517068

SCHEMBL9517068

CCCNC(=O)c1cccc(S(=O)(=O)NC(=O)c2ccc(CO)nc2)c1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 3/20 0.47
P4HTM Q9NXG6 3/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
ALDH1A1 P00352 3/20 0.45
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45
POLB P06746 1/20 0.45
KDM4E B2RXH2 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
PTGS2 P35354 1/20 0.40
PKM P14618 1/20 0.40
MAPK1 P28482 1/20 0.40
RAB9A P51151 2/20 0.40
HTT P42858 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9516171 0.92 SMN1; SMN2 (0.46) CASP3P4HTML3MBTL1KMT2AMEN1
SCHEMBL9519685 0.92 CASP3 (0.48) CASP3P4HTMKMT2AMEN1SMN1; SMN2
SCHEMBL9515549 0.88 KDM4E (0.52) P4HTMALDH1A1KMT2APOLBKDM4E
SCHEMBL9519516 0.84 HTT (0.60) CASP3P4HTML3MBTL1ALDH1A1POLB
SCHEMBL27379257 0.84 P4HTM (0.50) CASP3P4HTMPTGS2
SCHEMBL9518080 0.82 SMN1; SMN2 (0.47) CASP3P4HTMALDH1A1KMT2AMEN1
SCHEMBL9517927 0.82 P4HTM (0.42) CASP3P4HTMALDH1A1PTGS2
SCHEMBL8868877 0.81 SMN1; SMN2 (0.50) P4HTMKMT2AMEN1SMN1; SMN2
SCHEMBL9518038 0.81 ALDH1A1 (0.53) ALDH1A1KMT2ASMN1; SMN2RAB9AHTT
SCHEMBL8869795 0.80 P4HTM (0.51) CASP3P4HTMKMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed